Skip to content

Hepatitis delta virus co-infection increases risk of poor liver-related outcomes for people living with HIV

South African treatment guidelines need to consider viral load, not CD4 count, to achieve greater impact of treatment as prevention: study

Interferon-free BMS combo cures 90% of genotype 1 hepatitis C

Trevor Hawkins, from the Southwest CARE Center in New Mexico, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

HIV incidence is high among pregnant and postpartum women and increases the risk of mother-to-child transmission

Merck combination suppresses HCV in mono-infected and co-infected patients

Early treatment reduces viral reservoirs but does not prevent rebound

Afam Okoye, from the Vaccine and Gene Therapy Institute in Florida and the Oregon Health and Science University, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Dapivirine vaginal ring safe and effective in tissue study, but maraviroc component doesn't work

Beatrice Chen, of the University of Pittsburgh, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Early antiretroviral therapy may limit gut damage and immune activation

Women with circumcised partners less likely to have HIV, no less likely to use condoms